| Scrip Code | 512529 |
|---|---|
| NSE Symbol | SEQUENT |
| MSEI Symbol | NA |
| ISIN | INE807F01027 |
| Name of company | Sequent Scientific limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 14-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 03-11-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 14-11-2025 19:30:00 |
| End date and time of board meeting | 14-11-2025 20:26:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 42,399.00 | 86,541.00 | |
| Other income | 215.00 | 602.00 | |
| Total income | 42,614.00 | 87,143.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 18,279.00 | 36,248.00 |
| (b) | Purchases of stock-in-trade | 4,514.00 | 9,724.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (1,483.00) | (1,207.00) |
| (d) | Employee benefit expense | 8,169.00 | 16,076.00 |
| (e) | Finance costs | 1,351.00 | 2,767.00 |
| (f) | Depreciation, depletion and amortisation expense | 1,546.00 | 3,059.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 7,277.00 | 15,209.00 |
| 2 | Net Monetary (gain)/loss on Hyperinflation economy | 75.00 | (296.00) |
| Total other expenses | 7,352.00 | 14,913.00 | |
| Total expenses | 39,728.00 | 81,580.00 | |
| 3 | Total profit before exceptional items and tax | 2,886.00 | 5,563.00 |
| 4 | Exceptional items | (170.00) | (295.00) |
| 5 | Total profit before tax | 2,716.00 | 5,268.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 724.00 | 2,087.00 |
| 8 | Deferred tax | 32.00 | (536.00) |
| 9 | Total tax expenses | 756.00 | 1,551.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 1,960.00 | 3,717.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 1,960.00 | 3,717.00 |
| 17 | Other comprehensive income net of taxes | 1,435.00 | 4,610.00 |
| 18 | Total Comprehensive Income for the period | 3,395.00 | 8,327.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 1,474.00 | 2,905.00 | |
| Total profit or loss, attributable to non-controlling interests | 486.00 | 812.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 2,704.00 | 6,931.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 691.00 | 1,396.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 5,033.00 | 5,033.00 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.59 | 1.16 | |
| Diluted earnings (loss) per share from continuing operations | 0.58 | 1.14 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.59 | 1.16 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.58 | 1.14 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Refer published results for notes on financial results. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 29,749.00 | |
| Capital work-in-progress | 495.00 | |
| Investment property | 0.00 | |
| Goodwill | 27,465.00 | |
| Other intangible assets | 5,458.00 | |
| Intangible assets under development | 114.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 1.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | 942.00 | |
| Total non-current financial assets | 943.00 | |
| Deferred tax assets (net) | 10,928.00 | |
| Other non-current assets | 1,338.00 | |
| Total non-current assets | 76,490.00 | |
| 2 | Current assets | |
| Inventories | 41,809.00 | |
| Current financial asset | ||
| Current investments | 7.00 | |
| Trade receivables, current | 42,312.00 | |
| Cash and cash equivalents | 7,077.00 | |
| Bank balance other than cash and cash equivalents | 6.00 | |
| Loans, current | 18.00 | |
| Other current financial assets | 132.00 | |
| Total current financial assets | 49,552.00 | |
| Current tax assets (net) | 402.00 | |
| Other current assets | 4,360.00 | |
| Total current assets | 96,123.00 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 1,72,613.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 5,033.00 | |
| Other equity | 75,873.00 | |
| Total equity attributable to owners of parent | 80,906.00 | |
| Non controlling interest | 7,746.00 | |
| Total equity | 88,652.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 28,141.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | 2,469.00 | |
| Total non-current financial liabilities | 30,610.00 | |
| Provisions, non-current | 2,539.00 | |
| Deferred tax liabilities (net) | 375.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | 0.00 | |
| Total non-current liabilities | 33,524.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 17,424.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 22,742.00 | |
| Total Trade payable | 22,742.00 | |
| Other current financial liabilities | 4,535.00 | |
| Total current financial liabilities | 44,701.00 | |
| Other current liabilities | 3,500.00 | |
| Provisions, current | 649.00 | |
| Current tax liabilities (Net) | 1,587.00 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 50,437.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 83,961.00 | |
| Total equity and liabilites | 1,72,613.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement gain/(loss) on defined benefits plans | 400000 | 400000 |
| 2 | Fair value gain/(loss) from investment in equity instruments | -200000 | -200000 |
| Total Amount of items that will not be reclassified to profit and loss | 2.00 | 2.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 3.00 | 3.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange differences on translation of foreign operations | 88600000 | 285500000 |
| 2 | Exchange differences on net investment foreign operations | 55000000 | 175600000 |
| Total Amount of items that will be reclassified to profit and loss | 1,436.00 | 4,611.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 1,435.00 | 4,610.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 5,268.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 2,767.00 | |||||
| Adjustments for decrease (increase) in inventories | (2,481.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (3,991.00) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 0.00 | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | (11.00) | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 3,059.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 105.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 119.00 | |||||
| Adjustments for share-based payments | 1,995.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 1,324.00 | |||||
| Net cash flows from (used in) operations | 6,592.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 2,104.00 | |||||
| Other inflows (outflows) of cash | 2.00 | |||||
| Net cash flows from (used in) operating activities | 4,490.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 0.00 | |||||
| Purchase of property, plant and equipment | 1,610.00 | |||||
| Proceeds from sales of investment property | 345.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 155.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 688.00 | |||||
| Net cash flows from (used in) investing activities | (422.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 1,199.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 738.00 | |||||
| Payments of lease liabilities | 708.00 | |||||
| Dividends paid | 239.00 | |||||
| Interest paid | 2,771.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (3,257.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 811.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 811.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 6,266.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 7,077.00 | |||||
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | SRBC & CO LLP | Yes | 28-02-2026 | ||
|---|---|---|---|---|---|